Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis
Morozova O, Crawford FW, Cohen T, Paltiel AD, Altice FL. Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis. Addiction 2019, 115: 437-450. PMID: 31478285, PMCID: PMC7015766, DOI: 10.1111/add.14797.Peer-Reviewed Original ResearchConceptsOpioid agonist treatmentOpioid use disorderOAT coverageAgonist treatmentGross domestic productOpioid use initiationOpioid addiction epidemicOAT accessHIV epidemicUse disordersAddiction epidemicCapita gross domestic productPay thresholdsTreatment demandUse initiationAddiction treatmentIncremental costBaseline capacityTreatmentPotential peer effectsDomestic productTreatment spilloversEpidemicPeer effectsCoverage levelsDivergent estimates of HIV incidence among people who inject drugs in Ukraine
Morozova O, Booth RE, Dvoriak S, Dumchev K, Sazonova Y, Saliuk T, Crawford FW. Divergent estimates of HIV incidence among people who inject drugs in Ukraine. International Journal Of Drug Policy 2019, 73: 156-162. PMID: 31405731, PMCID: PMC6899203, DOI: 10.1016/j.drugpo.2019.07.023.Peer-Reviewed Original ResearchConceptsHIV incidenceStudy subjectsBio-behavioral surveillance surveysRecent syringe sharingPopulation of PWIDLongitudinal cohort studyDrug of choiceLow-risk individualsCross-sectional surveyBaseline characteristicsCohort studyAverage monthly numberRisk stratificationSyringe sharingIntervention trialsSurveillance SurveyHigh incidenceRisk individualsRCTsPWIDStudy designIncidenceDrugsFuture surveillanceSignificant differences